Get the Stockscreener App
1.10
1.85%
0.02
Oragenics Inc stock is traded at $1.10, with a volume of 49,253.
It is up +1.85% in the last 24 hours and down -20.29% over the past month.
Oragenics, Inc. focuses on developing antibiotics against infectious diseases and treatments for oral mucositis. It is developing OG716, an antibiotic product candidate, which is in nonclinical testing for healthcare-associated infections, as well as other homolog antibiotic product candidates. The company is also developing AG013, which is in Phase II clinical trial for the treatment of oral mucositis in cancer patients. Its product candidates also comprise LPT3-04, a naturally occurring dietary substance for weight loss; and SMaRT Replacement Therapy, a topical treatment applied to the teeth to protect against tooth decay. Oragenics, Inc. has collaboration agreements with Intrexon Corporation and its subsidiary, Intrexon Actobiotics NV to develop AG013 as a potential treatment of oral mucositis for cancer patients. It also has license agreements with LPThera LLC to develop LPT3-04, a weight-loss product candidate; and Texas A&M University System for access to new homologs of the lantibiotic Mutacin 1140 (MU1140) and other lantibiotics, as well as holds licenses from the University of Florida Research Foundation, Inc. for MU1140 product candidates. The company was formerly known as Oragen, Inc. Oragenics, Inc. was founded in 1996 and is headquartered in Tampa, Florida.
See More
Previous Close:
$1.08
Open:
$1.07
24h Volume:
49,253
Relative Volume:
0.08
Market Cap:
$4.54M
Revenue:
-
Net Income/Loss:
$-20.26M
P/E Ratio:
-0.1288
EPS:
-8.54
Net Cash Flow:
$-8.25M
1W Performance:
-4.35%
1M Performance:
-20.29%
6M Performance:
-87.17%
1Y Performance:
-95.93%
1-Day Range:
$1.07
$1.1265
1-Week Range:
$1.03
$1.16
52-Week Range:
$1.03
$40.80
Oragenics Inc Stock (OGEN) Company Profile
Name
Oragenics Inc
Sector
Industry
Phone
813-286-7900
Address
4902 Eisenhower Boulevard, Suite 125, Tampa, FL
Compare OGEN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OGEN
Oragenics Inc
|
1.10 | 4.54M | 0 | -20.26M | -8.25M | -8.54 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Oragenics Inc Stock (OGEN) Latest News
Oragenics Inc. stock momentum explainedTrade Volume Summary & Daily Chart Pattern Signals - Newser
What technical models suggest about Oragenics Inc.’s comebackDollar Strength & Long-Term Capital Growth Strategies - Newser
What to do if you’re stuck in Oragenics Inc.2025 Momentum Check & Safe Investment Capital Preservation Plans - Newser
How to forecast Oragenics Inc. trends using time seriesTake Profit & Fast Exit/Entry Strategy Plans - Newser
Using fundamentals and technicals on Oragenics Inc.Market Sentiment Report & Long-Term Safe Investment Plans - Newser
How sentiment analysis helps forecast Oragenics Inc.July 2025 Catalysts & Entry and Exit Point Strategies - Newser
Tools to assess Oragenics Inc.’s risk profileEarnings Overview Summary & Step-by-Step Swing Trade Plans - Newser
Applying chart zones and confluence areas to Oragenics Inc.July 2025 Gainers & Weekly High Conviction Trade Ideas - Newser
Has Oragenics Inc. found a price floorQuarterly Profit Report & Free Safe Capital Growth Stock Tips - Newser
Will Oragenics Inc. price bounce be sustainable2025 Biggest Moves & Step-by-Step Swing Trade Plans - Newser
Oragenics Inc. stock trend forecast2025 Support & Resistance & Free Technical Pattern Based Buy Signals - Newser
Strategies to average down on Oragenics Inc.2025 Big Picture & Free Safe Capital Growth Stock Tips - Newser
Smart tools for monitoring Oragenics Inc.’s price actionWeekly Market Report & Low Volatility Stock Recommendations - Newser
Is Oragenics Inc. the Top Chart Pick This Week2025 Investor Takeaways & Expert Verified Stock Movement Alerts - classian.co.kr
Real time social sentiment graph for Oragenics Inc.July 2025 Sentiment & Stock Market Timing Techniques - Newser
Building trade automation scripts for Oragenics Inc.July 2025 Action & Daily Volume Surge Signals - Newser
Backtesting results for Oragenics Inc. trading strategiesTrade Signal Summary & Safe Capital Investment Plans - Newser
Oragenics Inc. Stock Performance After Earnings: Historical InsightsJuly 2025 Opening Moves & Fast Gaining Stock Reports - Newser
Recovery Signals Appearing in Oragenics Inc. ChartsWeekly Stock Report & Real-Time Stock Price Movement Reports - metrotimes.co.kr
What makes Oragenics Inc. stock price move sharplyMarket Activity Summary & Free High Return Stock Watch Alerts - Newser
Oragenics Q2 EPS Beats Expectations, CEO Hails "New Era of Brain-First Recovery" - AInvest
Oragenics Secures $16.5M in Funding, Plans Q3 2025 Trials for Concussion Treatment - AInvest
Oragenics Inc Stock (OGEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):